drugset / Trial / NCT03852849

Rapid Build of HIV Related Protective Barriers

NCT03852849 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.

Timeline

Start
2019-03-01
Primary completion
2020-12-31
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject EFV Unknown 400 mg —

Indications

No indication recorded.